Skip to content
  • Twitter
  • Facebook
  • DMCA
  • Privacy Policy
  • Terms of Use
Market Newswire

Market Newswire

The Latest Press Releases

  • Business Wire
  • PR Newswire
  • Globe Newswire
  • OpenPR
  • IssueWire
  • US Newswire
  • SEC Filings
  • Toggle search form

Ardelyx, Inc. Reports Employment Inducement Grants

Posted on July 1, 2022 By News Desk

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that on June 28, 2022, the compensation committee of the company’s board of directors granted six new non-executive employees options to purchase an aggregate of 332,483 shares of the company’s common stock, and granted an aggregate of 83,375 Restricted Stock Units (RSUs) to eight new(…..) Continue reading »

PR Newswire

Post navigation

Previous Post: Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Next Post: Integra LifeSciences to Host Second Quarter 2022 Financial Results Conference Call on July 27, 2022

Archives

  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021

Categories

  • Business Wire
  • Globe Newswire
  • IssueWire
  • OpenPR
  • PR Newswire
  • SEC Filings
  • Uncategorized
  • US Newswire

Recent Posts

  • Ashland completes sale of land located in Ajax, Canada to Sunray Group of Hotels Inc, for CAD $12.25 million
  • 全球頂尖投資者法律顧問 ROSEN 鼓勵 Solana 投資者在證券集體訴訟的重要截止日期前尋求法律意見 – SOL
  • The Vitamin Club Gives Members Access To Affordable Nutritional Products
  • SaneChoice Is the Perfect Tech Partner for Businesses That Need an Unforgettable Web Presence
  • “Love Between Fairy and Devil” Has Been Launched on IQIYI International Website, An Innovative Masterpiece Derived from Oriental Culture

Copyright © 2022 Market Newswire.

Powered by PressBook WordPress theme

Go to mobile version